aluates Reports

$ 0.0

Automative

Global Bi-Specific Antibodies Therapy Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-31A12766

Global Bi Specific Antibodies Therapy Market Research Report 2023

BUY CHAPTERS

Global Bi-Specific Antibodies Therapy Market Research Report 2025

Code: QYRE-Auto-31A12766

Report

April 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Amgen Inc

Johnson & Johnson

Astrazeneca plc

AbbVie

Lindis Biotech

MacroGenics Inc

Genmab

Alphamab

Akeso, Inc.

Sanofi

Pfizer Inc

Bi-Specific Antibodies Therapy Market Size

The global market for Bi-Specific Antibodies Therapy was valued at US$ 5200 million in the year 2024 and is projected to reach a revised size of US$ 26250 million by 2031, growing at a CAGR of 26.4% during the forecast period.

Bi-Specific Antibodies Therapy Market

A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.

Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.

North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.

This report aims to provide a comprehensive presentation of the global market for Bi-Specific Antibodies Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bi-Specific Antibodies Therapy.

The Bi-Specific Antibodies Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bi-Specific Antibodies Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bi-Specific Antibodies Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bi-Specific Antibodies Therapy Market Report

Report Metric	Details
Report Name	Bi-Specific Antibodies Therapy Market
Accounted market size in year	US$ 5200 million
Forecasted market size in 2031	US$ 26250 million
CAGR	26.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Fragment-Based Antibodies IgG-Based Antibodies
Segment by Application	Cancer Haemophilia Other Non-Cancer Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, AbbVie, Lindis Biotech, MacroGenics, Inc, Genmab, Alphamab Co. Ltd, Akeso, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bi-Specific Antibodies Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Bi-Specific Antibodies Therapy Market growing?

Ans: The Bi-Specific Antibodies Therapy Market witnessing a CAGR of 26.4% during the forecast period 2025-2031.

What is the Bi-Specific Antibodies Therapy Market size in 2031?

Ans: The Bi-Specific Antibodies Therapy Market size in 2031 will be US$ 26250 million.

What is the market share of major companies in Bi-Specific Antibodies Therapy Market?

Ans: Global top five manufacturers hold a share over 95%.

What is the Bi-Specific Antibodies Therapy Market share by type?

Ans: In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%.

Who are the main players in the Bi-Specific Antibodies Therapy Market report?

Ans: The main players in the Bi-Specific Antibodies Therapy Market are Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, AbbVie, Lindis Biotech, MacroGenics, Inc, Genmab, Alphamab Co. Ltd, Akeso, Inc.

What are the Application segmentation covered in the Bi-Specific Antibodies Therapy Market report?

Ans: The Applications covered in the Bi-Specific Antibodies Therapy Market report are Cancer, Haemophilia, Other Non-Cancer Diseases

What are the Type segmentation covered in the Bi-Specific Antibodies Therapy Market report?

Ans: The Types covered in the Bi-Specific Antibodies Therapy Market report are Fragment-Based Antibodies, IgG-Based Antibodies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Fragment-Based Antibodies

1.2.3 IgG-Based Antibodies

1.3 Market by Application

1.3.1 Global Bi-Specific Antibodies Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Haemophilia

1.3.4 Other Non-Cancer Diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bi-Specific Antibodies Therapy Market Perspective (2020-2031)

2.2 Global Bi-Specific Antibodies Therapy Growth Trends by Region

2.2.1 Global Bi-Specific Antibodies Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Bi-Specific Antibodies Therapy Historic Market Size by Region (2020-2025)

2.2.3 Bi-Specific Antibodies Therapy Forecasted Market Size by Region (2026-2031)

2.3 Bi-Specific Antibodies Therapy Market Dynamics

2.3.1 Bi-Specific Antibodies Therapy Industry Trends

2.3.2 Bi-Specific Antibodies Therapy Market Drivers

2.3.3 Bi-Specific Antibodies Therapy Market Challenges

2.3.4 Bi-Specific Antibodies Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue

3.1.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue (2020-2025)

3.1.2 Global Bi-Specific Antibodies Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Bi-Specific Antibodies Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Bi-Specific Antibodies Therapy Revenue

3.4 Global Bi-Specific Antibodies Therapy Market Concentration Ratio

3.4.1 Global Bi-Specific Antibodies Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific Antibodies Therapy Revenue in 2024

3.5 Global Key Players of Bi-Specific Antibodies Therapy Head office and Area Served

3.6 Global Key Players of Bi-Specific Antibodies Therapy, Product and Application

3.7 Global Key Players of Bi-Specific Antibodies Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Bi-Specific Antibodies Therapy Breakdown Data by Type

4.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Type (2020-2025)

4.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Type (2026-2031)

5 Bi-Specific Antibodies Therapy Breakdown Data by Application

5.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Application (2020-2025)

5.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Bi-Specific Antibodies Therapy Market Size (2020-2031)

6.2 North America Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Bi-Specific Antibodies Therapy Market Size by Country (2020-2025)

6.4 North America Bi-Specific Antibodies Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bi-Specific Antibodies Therapy Market Size (2020-2031)

7.2 Europe Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Bi-Specific Antibodies Therapy Market Size by Country (2020-2025)

7.4 Europe Bi-Specific Antibodies Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size (2020-2031)

8.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bi-Specific Antibodies Therapy Market Size (2020-2031)

9.2 Latin America Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2020-2025)

9.4 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size (2020-2031)

10.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Bi-Specific Antibodies Therapy Introduction

11.1.4 Roche Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Bi-Specific Antibodies Therapy Introduction

11.2.4 Amgen Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Bi-Specific Antibodies Therapy Introduction

11.3.4 Sanofi Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Bi-Specific Antibodies Therapy Introduction

11.4.4 Pfizer Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Introduction

11.5.4 Johnson & Johnson Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Bi-Specific Antibodies Therapy Introduction

11.6.4 AstraZeneca Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 AbbVie

11.7.1 AbbVie Company Details

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Bi-Specific Antibodies Therapy Introduction

11.7.4 AbbVie Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.7.5 AbbVie Recent Development

11.8 Lindis Biotech

11.8.1 Lindis Biotech Company Details

11.8.2 Lindis Biotech Business Overview

11.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Introduction

11.8.4 Lindis Biotech Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.8.5 Lindis Biotech Recent Development

11.9 MacroGenics, Inc

11.9.1 MacroGenics, Inc Company Details

11.9.2 MacroGenics, Inc Business Overview

11.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Introduction

11.9.4 MacroGenics, Inc Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.9.5 MacroGenics, Inc Recent Development

11.10 Genmab

11.10.1 Genmab Company Details

11.10.2 Genmab Business Overview

11.10.3 Genmab Bi-Specific Antibodies Therapy Introduction

11.10.4 Genmab Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.10.5 Genmab Recent Development

11.11 Alphamab Co. Ltd

11.11.1 Alphamab Co. Ltd Company Details

11.11.2 Alphamab Co. Ltd Business Overview

11.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Introduction

11.11.4 Alphamab Co. Ltd Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.11.5 Alphamab Co. Ltd Recent Development

11.12 Akeso, Inc.

11.12.1 Akeso, Inc. Company Details

11.12.2 Akeso, Inc. Business Overview

11.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Introduction

11.12.4 Akeso, Inc. Revenue in Bi-Specific Antibodies Therapy Business (2020-2025)

11.12.5 Akeso, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Amgen Inc

Johnson & Johnson

Astrazeneca plc

AbbVie

Lindis Biotech

MacroGenics Inc

Genmab

Alphamab

Akeso, Inc.

Sanofi

Pfizer Inc

List of Tables

Table 1. Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Fragment-Based Antibodies

Table 3. Key Players of IgG-Based Antibodies

Table 4. Global Bi-Specific Antibodies Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Bi-Specific Antibodies Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Bi-Specific Antibodies Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Bi-Specific Antibodies Therapy Market Share by Region (2020-2025)

Table 8. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Bi-Specific Antibodies Therapy Market Share by Region (2026-2031)

Table 10. Bi-Specific Antibodies Therapy Market Trends

Table 11. Bi-Specific Antibodies Therapy Market Drivers

Table 12. Bi-Specific Antibodies Therapy Market Challenges

Table 13. Bi-Specific Antibodies Therapy Market Restraints

Table 14. Global Bi-Specific Antibodies Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Bi-Specific Antibodies Therapy Market Share by Players (2020-2025)

Table 16. Global Top Bi-Specific Antibodies Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies Therapy as of 2024)

Table 17. Ranking of Global Top Bi-Specific Antibodies Therapy Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Bi-Specific Antibodies Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Bi-Specific Antibodies Therapy, Headquarters and Area Served

Table 20. Global Key Players of Bi-Specific Antibodies Therapy, Product and Application

Table 21. Global Key Players of Bi-Specific Antibodies Therapy, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Bi-Specific Antibodies Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Bi-Specific Antibodies Therapy Revenue Market Share by Type (2020-2025)

Table 25. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Bi-Specific Antibodies Therapy Revenue Market Share by Type (2026-2031)

Table 27. Global Bi-Specific Antibodies Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Bi-Specific Antibodies Therapy Revenue Market Share by Application (2020-2025)

Table 29. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Bi-Specific Antibodies Therapy Revenue Market Share by Application (2026-2031)

Table 31. North America Bi-Specific Antibodies Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Bi-Specific Antibodies Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Bi-Specific Antibodies Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Bi-Specific Antibodies Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Bi-Specific Antibodies Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Bi-Specific Antibodies Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Bi-Specific Antibodies Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Bi-Specific Antibodies Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Bi-Specific Antibodies Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Bi-Specific Antibodies Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Bi-Specific Antibodies Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Bi-Specific Antibodies Therapy Product

Table 49. Roche Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Amgen Company Details

Table 52. Amgen Business Overview

Table 53. Amgen Bi-Specific Antibodies Therapy Product

Table 54. Amgen Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. Sanofi Company Details

Table 57. Sanofi Business Overview

Table 58. Sanofi Bi-Specific Antibodies Therapy Product

Table 59. Sanofi Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 60. Sanofi Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Bi-Specific Antibodies Therapy Product

Table 64. Pfizer Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Bi-Specific Antibodies Therapy Product

Table 69. Johnson & Johnson Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Bi-Specific Antibodies Therapy Product

Table 74. AstraZeneca Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. AbbVie Company Details

Table 77. AbbVie Business Overview

Table 78. AbbVie Bi-Specific Antibodies Therapy Product

Table 79. AbbVie Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 80. AbbVie Recent Development

Table 81. Lindis Biotech Company Details

Table 82. Lindis Biotech Business Overview

Table 83. Lindis Biotech Bi-Specific Antibodies Therapy Product

Table 84. Lindis Biotech Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 85. Lindis Biotech Recent Development

Table 86. MacroGenics, Inc Company Details

Table 87. MacroGenics, Inc Business Overview

Table 88. MacroGenics, Inc Bi-Specific Antibodies Therapy Product

Table 89. MacroGenics, Inc Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 90. MacroGenics, Inc Recent Development

Table 91. Genmab Company Details

Table 92. Genmab Business Overview

Table 93. Genmab Bi-Specific Antibodies Therapy Product

Table 94. Genmab Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 95. Genmab Recent Development

Table 96. Alphamab Co. Ltd Company Details

Table 97. Alphamab Co. Ltd Business Overview

Table 98. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Product

Table 99. Alphamab Co. Ltd Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 100. Alphamab Co. Ltd Recent Development

Table 101. Akeso, Inc. Company Details

Table 102. Akeso, Inc. Business Overview

Table 103. Akeso, Inc. Bi-Specific Antibodies Therapy Product

Table 104. Akeso, Inc. Revenue in Bi-Specific Antibodies Therapy Business (2020-2025) & (US$ Million)

Table 105. Akeso, Inc. Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Bi-Specific Antibodies Therapy Picture

Figure 2. Global Bi-Specific Antibodies Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bi-Specific Antibodies Therapy Market Share by Type: 2024 VS 2031

Figure 4. Fragment-Based Antibodies Features

Figure 5. IgG-Based Antibodies Features

Figure 6. Global Bi-Specific Antibodies Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Bi-Specific Antibodies Therapy Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Haemophilia Case Studies

Figure 10. Other Non-Cancer Diseases Case Studies

Figure 11. Bi-Specific Antibodies Therapy Report Years Considered

Figure 12. Global Bi-Specific Antibodies Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Bi-Specific Antibodies Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Bi-Specific Antibodies Therapy Market Share by Region: 2024 VS 2031

Figure 15. Global Bi-Specific Antibodies Therapy Market Share by Players in 2024

Figure 16. Global Top Bi-Specific Antibodies Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies Therapy as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Bi-Specific Antibodies Therapy Revenue in 2024

Figure 18. North America Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Bi-Specific Antibodies Therapy Market Share by Country (2020-2031)

Figure 20. United States Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Bi-Specific Antibodies Therapy Market Share by Country (2020-2031)

Figure 24. Germany Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Bi-Specific Antibodies Therapy Market Share by Region (2020-2031)

Figure 32. China Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Bi-Specific Antibodies Therapy Market Share by Country (2020-2031)

Figure 40. Mexico Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Bi-Specific Antibodies Therapy Market Share by Country (2020-2031)

Figure 44. Turkey Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Bi-Specific Antibodies Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 48. Amgen Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 51. Johnson & Johnson Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 53. AbbVie Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 54. Lindis Biotech Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 55. MacroGenics, Inc Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 56. Genmab Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 57. Alphamab Co. Ltd Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 58. Akeso, Inc. Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bispecific Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bispecific Antibody Therapeutic Market Insights Forecast to 2030

Global Bispecific Monoclonal Antibodies Market Research Report 2024

Global Bi Specific MAbS Market Research Report 2024

Global Bispecific Antibodies Drug Market Research Report 2025

Global Bispecific Antibody Development Platform Market Research Report 2024

Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030

Global Bispecific Antibody Molecular Drug Market Research Report 2025

Global T Cell NK Cell Engaging Bispecific Antibodies Market Research Report 2025

Global Humanized Bispecific Antibody Market Research Report 2024

Global BCMA CD3 Bispecific Antibody Market Research Report 2024

Global Humanized Bispecific Antibodies Market Research Report 2024

Global Next Generation Antibody Therapeutics Market Research Report 2025

Global Cell bridging Bispecific Antibodies Market Research Report 2025

Global Single Domain Antibody sdAbs Drugs Market Research Report 2024

Global Cancer Monoclonal Antibody Partnering Terms and Agreements Market Insights Forecast to 2030

BAF53 Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bcl 2 Antibody Market Research Report 2024

Bispecific and Trispecific Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions